Composite Dietary Antioxidant Index and Metabolic Health in Overweight/Obesity in U.S. Adults
NCT ID: NCT07291726
Last Updated: 2025-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38646 participants
OBSERVATIONAL
2024-04-01
2024-08-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CDAI Q1 (Lowest Quartile)
None (Observational)
This is an observational study with no active intervention implemented. Its primary aim is to analyze the relationship between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the associated metabolic abnormalities, using the dataset-with no experimental manipulation involved.
CDAI Q2 (Second Quartile)
None (Observational)
This is an observational study with no active intervention implemented. Its primary aim is to analyze the relationship between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the associated metabolic abnormalities, using the dataset-with no experimental manipulation involved.
CDAI Q3 (Third Quartile)
None (Observational)
This is an observational study with no active intervention implemented. Its primary aim is to analyze the relationship between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the associated metabolic abnormalities, using the dataset-with no experimental manipulation involved.
CDAI Q4 (Highest Quartile)
None (Observational)
This is an observational study with no active intervention implemented. Its primary aim is to analyze the relationship between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the associated metabolic abnormalities, using the dataset-with no experimental manipulation involved.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
None (Observational)
This is an observational study with no active intervention implemented. Its primary aim is to analyze the relationship between the Composite Dietary Antioxidant Index (CDAI) and overweight/obesity, as well as the associated metabolic abnormalities, using the dataset-with no experimental manipulation involved.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with complete body mass index (BMI) data from the NHANES database
* Individuals aged 18 years and older
Exclusion Criteria
* Individuals who are pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University-Town Hospital of Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jiang Peng
Attending Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Town Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NHANES_CrossSec_2025_01
Identifier Type: -
Identifier Source: org_study_id